New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
about
Phosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen productionMesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in miceInhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transitionStem cells and cell therapies in lung biology and lung diseasesA prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation.FIZZ2/RELM-β induction and role in pulmonary fibrosisInfluence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis.Interstitial lung diseases in children.FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt/mTOR kinasesProfibrotic potential of prominin-1+ epithelial progenitor cells in pulmonary fibrosisPathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrixThe secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factorReduced FoxO3a expression causes low autophagy in idiopathic pulmonary fibrosis fibroblasts on collagen matrices.Rapamycin inhibits transforming growth factor β1-induced fibrogenesis in primary human lung fibroblastsThe inter-connection between fibrosis and microvascular remodeling in idiopathic pulmonary fibrosis: Reality or just a phenomenon.Current and emerging drugs for idiopathic pulmonary fibrosis.Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.Mesenchymal stem cells in tissue repairVitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cellsPromising molecular targets and biomarkers for male BPH and LUTSOriginal Research: ACE2 activator associated with physical exercise potentiates the reduction of pulmonary fibrosis.Determinants of initiation and progression of idiopathic pulmonary fibrosis.Endoplasmic reticulum stress, a new wrestler, in the pathogenesis of idiopathic pulmonary fibrosis.Stem cells: a model for screening, discovery and development of drugs.TGF-β1 as a therapeutic target for pulmonary fibrosis and COPD.Studying human respiratory disease in animals--role of induced and naturally occurring models.Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s).Direct regulation of transforming growth factor β-induced epithelial-mesenchymal transition by the protein phosphatase activity of unphosphorylated PTEN in lung cancer cells.Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.An essential role for fibronectin extra type III domain A in pulmonary fibrosis.Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats.Morphological and molecular markers in idiopathic pulmonary fibrosis
P2860
Q23924071-33E808EF-D490-4CB2-8F95-F2FB7A5A8766Q28596834-338E01D8-118B-444B-9267-97812F34C74FQ29346955-0A59ECE4-3E4E-4340-B35A-29E20C0DE270Q30486086-C27E8D4E-4FC7-429F-8A8A-192F0906A45AQ30541785-2C49EB8B-4E12-4294-B344-5BA4D5EB5A91Q33426873-C1BFCF69-6507-4A8E-A89F-BD07D596472CQ33577529-A69760D2-E9C9-4C2F-A246-EB16D1940CCAQ33648682-B9FA282B-D47D-4EB2-9539-26347579BD4BQ33785553-7393AB68-AE98-4E1D-AF9D-1A653C1E9504Q34128163-6A1BC984-543C-4A27-946A-A971605AA593Q34666156-6322D2BE-58E4-4BEA-8C2A-CAF0D8881468Q35005706-CF571DB0-412D-4B5E-8EFA-B64B1B2D3E35Q35146728-9FC1DC7F-3054-4BC4-9183-9DB5F01D6363Q35321400-A0638D90-E61E-475F-A9A0-6E94D1175B0CQ35474548-5606C206-22CC-41F8-8D46-EFDF673C8A1DQ35654823-E9D8D1C1-1B0D-415F-AC3C-AD7B58287A31Q36066475-9FEA6B1E-76E9-418C-B8D6-5BCBE00CF2F0Q36620443-DF77AEBC-EEB3-4413-9378-F6D3F0BB81BAQ36766700-F74848A4-92E9-4DEB-B5C8-C7D306E949BDQ36989934-B3A5D39D-3622-4316-9326-EDCA91954C6AQ36991705-DB6C5378-DB54-42AE-A81C-5EE4FCAC46E0Q37089825-5627EAF8-7192-4EAF-A729-6862364EA274Q37142817-C29FA99F-3F6B-4CA4-8C0C-3A0E31F0A45AQ37208027-B2862975-9A11-46E3-BB74-B4CE0D609E5BQ37364472-D27F9B07-3622-4757-B95A-CD73A6D48C3FQ37551131-30DF4619-2431-455A-9DC0-3646FA1DEE54Q37594222-3B4D3379-DED0-441E-9D23-F879EB63AAF8Q37685292-322F8115-217D-407B-9373-AB4D64893D2DQ38160462-CC5DDE9A-766E-4400-ADCC-ACF7B917C6BBQ38177343-07515CE2-A1BF-4A0F-A338-F78C3A319BC6Q38607416-41E8B47D-057A-4352-BC38-2D3D3C8C5697Q38824212-B14BA816-8B9F-4BC1-8F85-D39E5FAA34C8Q38829337-3C6C7937-80A8-4FF5-A2AE-E0033F2A8198Q39797229-7C6743FA-802E-4F57-8BF2-B6002FF0633AQ40905189-F7CE71F8-96A0-46C6-A70D-5C998D47611EQ41443789-4507AC9A-58CE-49C2-BD80-F81658C1D1D8Q42444492-BE3D04D3-AB28-4B52-AB9E-A3CADA04D85FQ43075944-724EE82A-753E-4D54-8E9E-93C7451E83E1Q52718255-6D560483-E687-4B81-9E68-9662EF6E9DE0Q58004304-AED6B3DC-E8A1-41AC-9772-4B22829CB62E
P2860
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New insights into the pathogen ...... and implications for therapy.
@en
type
label
New insights into the pathogen ...... and implications for therapy.
@en
prefLabel
New insights into the pathogen ...... and implications for therapy.
@en
P2093
P2860
P1476
New insights into the pathogen ...... a and implications for therapy
@en
P2093
Margaret R Gyetko
Mehrnaz Gharaee-Kermani
P2860
P304
P356
10.1007/S11095-006-9216-X
P50
P577
2007-03-01T00:00:00Z